CCRA welcomes Dr. Sara Urowitz as its new Executive Director. Sara has a PhD in Health Policy and Bioethics and was most recently the Group Manager, Palliative Care and the Ontario Palliative Care Network Secretariat at Cancer Care Ontario. Sara is also an Assistant Professor in the Institute of Health Policy, Management and Evaluation at the University of Toronto. With a background in strategic planning, palliative care, and cancer survivorship, Sara is well placed to facilitate CCRA's work in these areas.
At the recent CCRA Member Meeting, Dr. Stephen Robbins, Scientific Director, CIHR Institute of Cancer Research and Associate Professor, Departments of Oncology, Biochemistry & Molecular Biology, at the University of Calgary, became the incoming CCRA co-chair. Dr. Robbins was elected from among the organizational representatives and will serve a two-year term. Congratulations, Steve!
Members recognized the invaluable contributions of outgoing co-chair, Dr. Christine Williams, Chief Mission Officer and Scientific Director, Canadian Cancer Society, who served for three years. Dr. Williams played an instrumental role in the development of Target 2020, the delivery of the 2013 and 2015 research conferences, and the reports on cancer research investment. Thank you, Christine!
CCRA released the new cancer research investment figures for 2013. This brief report shows an annual investment of $498M for 2013, higher than the first four years of the survey, but the lowest amount since 2008. Much of the decline from 2009 to 2013 was attributable to reduced cancer-relevant investment from the Canada Foundation for Innovation and from provincial sources in Ontario. The investment in operating grants, however, continued its year-upon-year increase, with the ongoing trend of greater investment from “focused” funding programs compared to open operating grants. To access this report, detailed tables, and a companion slide deck, click here.
The Canadian Cancer Research Conference (November 8-10, Montréal – Hôtel Bonaventure) continued its tradition of providing a scientific program that covers the full spectrum of cancer research with presentations by several of the country’s leading researchers. New to this year was a “Headline News” symposium, during which top researchers shared their recently released research findings. The conference was attended by 983 participants, about half of whom were trainees. For more information about the Conference, click here.